First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

526 Reviews

Credit Rating - CANCER, GENOMICS AND CONSULTING LTD

ANALYSIS
Credit Risk Update: CANCER, GENOMICS AND CONSULTING LTD, CART HOUSE 2, COPLEY HILL BUSINESS PARK CAMBRIDGE ROAD, BABRAHAM, CAMBRIDGE, CB22 3GN. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 30 June 2024. The company was incorporated on 16 July 2021.

The accounts next due date is 31 March 2026. There are no mortgages.

The above was based on public record information as at 27 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: 13515820
Date Incorporated: 16 July 2021
Date Latest Accounts: 30 June 2024
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: 13515820
Annual Return: Unknown
Registered Office: CART HOUSE 2, COPLEY HILL BUSINESS PARK CAMBRIDGE ROAD, BABRAHAM, CAMBRIDGE, CB22 3GN
SIC Code and Operations: 62020,71122,72110,86220
SECURED CREDITORS
Number of Mortgages 0
Satisfied Mortgages 0
Part Satisfied Mortgages 0
Unsatisfied Mortgages 0
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

CANCER, GENOMICS AND CONSULTING LTD

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 7 October 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
02803321 CANCERBACKUP Active
15850109 CANCERBAE CIC Active
06241210 CANCERCARE (NORTH LANCASHIRE & SOUTH CUMBRIA) Active
15351372 CANCERCAREHUB COMMUNITY INTEREST COMPANY Active
10544655 CANCERCLEAR LIMITED Dissolved

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd